Literature DB >> 12408772

Percutaneous microwave coagulation therapy for lung cancer.

Weijian Feng1, Wei Liu, Caiying Li, Zhigang Li, Ruxun Li, Fengling Liu, Baoe Zhai, Jian Shi, Gaofeng Shi.   

Abstract

OBJECTIVE: To evaluate the clinical effect, CT image changes and side-effects of percutaneous microwave coagulation therapy for lung cancer.
METHODS: CT-guided percutaneous puncture was performed using a needle mono-pole microwave antenna with 65W, 2 450 MHz microwave delivered in 60 seconds to 20 peripheral lung cancer patients, including 8 suffering from primary lung cancer and 12 metastatic lung cancer (totally 28 lesions).
RESULTS: Sixteen patients were alive after having been followed-up for 3 approximately 24 months. All patients showed nodules decreased in size. Diminution of over 50% was observed in 13 nodules and 3, completely disappeared. The overall response rate was 57.1%. Ellipsoid shadow 3.5 cm x 2.5 cm across was observed by CT in lesions immediately after coagulation. Gasification within the coagulated area was observed in a week with a high density in the peripheral region. Consolidation was observed in 3 months and the lesion disappeared 1 year later. Complete tumor necrosis was proved by biopsy. No side-effects or complications were observed.
CONCLUSION: Percutaneous microwave coagulation therapy is a new safe treatment for lung cancer, giving marked effect but minimum trauma.

Entities:  

Mesh:

Year:  2002        PMID: 12408772

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  12 in total

1.  Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model.

Authors:  Christopher L Brace; J Louis Hinshaw; Paul F Laeseke; Lisa A Sampson; Fred T Lee
Journal:  Radiology       Date:  2009-03-31       Impact factor: 11.105

2.  Microwave ablation therapy for treating primary and secondary lung tumours: technical note.

Authors:  G Carrafiello; M Mangini; I De Bernardi; F Fontana; G Dionigi; S Cuffari; A Imperatori; D Laganà; C Fugazzola
Journal:  Radiol Med       Date:  2010-03-29       Impact factor: 3.469

Review 3.  Alternative to surgery in early stage NSCLC-interventional radiologic approaches.

Authors:  Kyungmouk Steve Lee; Bradley B Pua
Journal:  Transl Lung Cancer Res       Date:  2013-10

4.  Treatment of lung tumours with high-energy microwave ablation: a single-centre experience.

Authors:  Anna Maria Ierardi; Andrea Coppola; Natalie Lucchina; Gianpaolo Carrafiello
Journal:  Med Oncol       Date:  2016-11-30       Impact factor: 3.064

Review 5.  Alternatives to surgery for early stage non-small cell lung cancer-ready for prime time?

Authors:  Millie Das; Mohamed H K Abdelmaksoud; Billy W Loo; Nishita Kothary
Journal:  Curr Treat Options Oncol       Date:  2010-06

Review 6.  Thermal ablation of lung tumors.

Authors:  P David Sonntag; J Louis Hinshaw; Meghan G Lubner; Christopher L Brace; Fred T Lee
Journal:  Surg Oncol Clin N Am       Date:  2011-04       Impact factor: 3.495

Review 7.  Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients.

Authors:  Guy C Jones; Jason D Kehrer; Jenna Kahn; Bobby N Koneru; Ram Narayan; Tarita O Thomas; Kevin Camphausen; Minesh P Mehta; Aradhana Kaushal
Journal:  Clin Lung Cancer       Date:  2015-04-23       Impact factor: 4.785

8.  Radiofrequency versus microwave ablation for treatment of the lung tumours: LUMIRA (lung microwave radiofrequency) randomized trial.

Authors:  M Macchi; M P Belfiore; C Floridi; N Serra; G Belfiore; L Carmignani; R F Grasso; E Mazza; C Pusceddu; L Brunese; G Carrafiello
Journal:  Med Oncol       Date:  2017-04-18       Impact factor: 3.064

Review 9.  Lung cancer ablation: technologies and techniques.

Authors:  Erica S Alexander; Damian E Dupuy
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

10.  Percutaneous thermal ablation for stage IA non-small cell lung cancer: long-term follow-up.

Authors:  Chaitan K Narsule; Praveen Sridhar; Divya Nair; Avneesh Gupta; Roy G Oommen; Michael I Ebright; Virginia R Litle; Hiran C Fernando
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.